MX360002B - Formulaciones mejoradas para dispositivos médicos recubiertos con medicamento. - Google Patents

Formulaciones mejoradas para dispositivos médicos recubiertos con medicamento.

Info

Publication number
MX360002B
MX360002B MX2014006898A MX2014006898A MX360002B MX 360002 B MX360002 B MX 360002B MX 2014006898 A MX2014006898 A MX 2014006898A MX 2014006898 A MX2014006898 A MX 2014006898A MX 360002 B MX360002 B MX 360002B
Authority
MX
Mexico
Prior art keywords
drug
medical devices
coated medical
lubricant
lipophilic
Prior art date
Application number
MX2014006898A
Other languages
English (en)
Other versions
MX2014006898A (es
Inventor
Madeleine Caroline Berg
Thomas Speck
Original Assignee
Innora Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innora Gmbh filed Critical Innora Gmbh
Publication of MX2014006898A publication Critical patent/MX2014006898A/es
Publication of MX360002B publication Critical patent/MX360002B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/104—Balloon catheters used for angioplasty
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/452—Lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/10—Materials for lubricating medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Child & Adolescent Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con un dispositivo médico que lleva, al menos sobre una porción de su superficie, por lo menos un medicamento o preparación farmacéutica y por lo menos un lubricante lipofílico en una proporción de 0.1 a 500% en peso del por lo menos un lubricante con respecto al 100% en peso del medicamento, en donde el por lo menos un medicamento se selecciona del grupo de paclitaxel, trióxido de arsénico y derivados lipofílicos de corticoides y medicamentos seleccionados de la familia Limus, y el por lo menos un lubricante lipofílico es una sal de ácido C6-C30-monocarboxílico.
MX2014006898A 2011-12-23 2012-12-14 Formulaciones mejoradas para dispositivos médicos recubiertos con medicamento. MX360002B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2011/073946 WO2013091722A1 (en) 2011-12-23 2011-12-23 Drug-coated medical devices
PCT/EP2012/075563 WO2013092416A1 (en) 2011-12-23 2012-12-14 Drug-coated medical devices

Publications (2)

Publication Number Publication Date
MX2014006898A MX2014006898A (es) 2014-09-04
MX360002B true MX360002B (es) 2018-10-18

Family

ID=47458936

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014006898A MX360002B (es) 2011-12-23 2012-12-14 Formulaciones mejoradas para dispositivos médicos recubiertos con medicamento.

Country Status (12)

Country Link
US (1) US9233191B2 (es)
EP (1) EP2793967B1 (es)
JP (1) JP6174038B2 (es)
KR (1) KR101943143B1 (es)
CN (1) CN104010671B (es)
AU (1) AU2012358032B2 (es)
BR (1) BR112014014814B1 (es)
CA (1) CA2857410C (es)
ES (1) ES2550350T3 (es)
MX (1) MX360002B (es)
SG (1) SG11201402654TA (es)
WO (2) WO2013091722A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013110294B4 (de) * 2013-09-18 2016-07-07 Innora Gmbh Limus-Depot-Formulierung auf Ballonkathetern
US9675734B2 (en) 2014-08-29 2017-06-13 Invatec S.P.A. Medical balloon coated with therapeutic agent, carboxylic acid, and salt thereof
MX2018004052A (es) 2015-10-02 2019-01-14 Ethicon Inc Metodos y sistemas para tratar fluidos y dispositivos medicos.
EP3445220B1 (en) * 2016-04-19 2022-11-02 Boston Scientific Scimed, Inc. Weeping balloon devices
AU2017328714B2 (en) * 2016-09-19 2022-05-12 Biotronik Ag Polymer-free drug eluting vascular stents
CN108211094B (zh) * 2016-12-19 2023-12-05 先健科技(深圳)有限公司 药物涂层球囊
US11826492B2 (en) 2016-12-22 2023-11-28 Biotronik Ag Intratumoral drug delivery materials and methods for treating breast cancer
CN111944595B (zh) * 2020-08-21 2022-08-09 健尔康医疗科技股份有限公司 一种医用外科器械用润滑剂及其制备和使用方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146358A (en) 1989-03-14 2000-11-14 Cordis Corporation Method and apparatus for delivery of therapeutic agent
US5674192A (en) 1990-12-28 1997-10-07 Boston Scientific Corporation Drug delivery
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5199951A (en) 1990-05-17 1993-04-06 Wayne State University Method of drug application in a transporting medium to an arterial wall injured during angioplasty
US5893840A (en) 1991-01-04 1999-04-13 Medtronic, Inc. Releasable microcapsules on balloon catheters
US5324261A (en) 1991-01-04 1994-06-28 Medtronic, Inc. Drug delivery balloon catheter with line of weakness
WO1994023787A1 (en) 1993-04-22 1994-10-27 Rammler David H Sampling balloon catheter
US6159978A (en) 1997-05-28 2000-12-12 Aventis Pharmaceuticals Product, Inc. Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
US6306166B1 (en) 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
US7445792B2 (en) 2003-03-10 2008-11-04 Abbott Laboratories Medical device having a hydration inhibitor
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
US8182527B2 (en) * 2001-05-07 2012-05-22 Cordis Corporation Heparin barrier coating for controlled drug release
DK1576970T3 (da) 2001-11-08 2010-07-12 Ziscoat N V Intraluminal indretning med en coating, der indeholder et terapeutisk middel
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
US7108684B2 (en) 2003-01-02 2006-09-19 Novoste Corporation Drug delivery balloon catheter
US20040213826A1 (en) * 2003-04-28 2004-10-28 Marx Steven O. Medical devices and methods for inhibiting proliferation of smooth muscle cells
JP2007505655A (ja) 2003-09-15 2007-03-15 アトリウム メディカル コーポレーション 多孔性医療用具を用いた治療物質の組織部位への塗布
CN102258811B (zh) 2006-07-03 2015-03-11 汉莫堤克股份有限公司 持久使血管开的活性物释放医药产品的制造、方法和使用
EP1913962A1 (en) * 2006-10-22 2008-04-23 Ophir Perelson Expandable medical device for the treatment and prevention of cardiovascular diseases
US8414909B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
EP2491962A1 (de) * 2007-01-21 2012-08-29 Hemoteq AG Medizinprodukt zur Behandlung von Verschlüssen von Körperdurchgängen und zur Prävention drohender Wiederverschlüsse
DE102007036685A1 (de) 2007-08-03 2009-02-05 Innora Gmbh Verbesserte arzneimittelbeschichtete Medizinprodukte deren Herstellung und Verwendung
MX2010005550A (es) 2007-11-21 2010-09-09 Invatec Spa Globo para el tratamiento de estenosis y metodo para fabricar el globo.
EP2271379B1 (en) 2008-03-28 2015-11-25 SurModics, Inc. Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery
US8092822B2 (en) * 2008-09-29 2012-01-10 Abbott Cardiovascular Systems Inc. Coatings including dexamethasone derivatives and analogs and olimus drugs
JP2012504654A (ja) * 2008-10-03 2012-02-23 エリクシアー メディカル コーポレイション 多環状ラクトン化合物およびその使用方法
EP2381963A4 (en) 2009-01-21 2014-07-02 Meril Life Sciences Private Ltd MEDICAL DEVICE WITH FORMULATIONS FOR TARGETED DELIVERY OF A BIOLOGICALLY ACTIVE SUBSTANCE (SUBSTANCES) AND METHOD OF MANUFACTURING THE SAME
EP2380605A1 (en) * 2010-04-19 2011-10-26 InnoRa Gmbh Improved formulations for drug-coated medical devices
EP2380604A1 (en) * 2010-04-19 2011-10-26 InnoRa Gmbh Improved coating formulations for scoring or cutting balloon catheters
JP5985474B2 (ja) * 2010-08-04 2016-09-06 メリル ライフ サイエンシズ ピーブィティ．エルティディ 抗増殖特性を有する新規４２−ｏ−（ヘテロアルコキシアルキル）ラパマイシン化合物の調製プロセス

Also Published As

Publication number Publication date
WO2013091722A1 (en) 2013-06-27
JP6174038B2 (ja) 2017-08-02
MX2014006898A (es) 2014-09-04
AU2012358032B2 (en) 2015-09-17
KR20140121819A (ko) 2014-10-16
WO2013092416A1 (en) 2013-06-27
KR101943143B1 (ko) 2019-01-28
BR112014014814B1 (pt) 2020-04-22
CN104010671B (zh) 2016-05-04
US20140322291A1 (en) 2014-10-30
JP2015502225A (ja) 2015-01-22
CN104010671A (zh) 2014-08-27
US9233191B2 (en) 2016-01-12
EP2793967A1 (en) 2014-10-29
BR112014014814A8 (pt) 2017-06-13
CA2857410C (en) 2019-01-08
EP2793967B1 (en) 2015-08-26
BR112014014814A2 (pt) 2017-06-13
ES2550350T3 (es) 2015-11-06
AU2012358032A1 (en) 2014-06-12
SG11201402654TA (en) 2014-09-26
CA2857410A1 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
MX360002B (es) Formulaciones mejoradas para dispositivos médicos recubiertos con medicamento.
PH12016502582A1 (en) TrK-INHIBITING COMPOUND
GT201300243A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso
WO2011148316A3 (en) Drug-delivery accessory for an implantable medical device
WO2013085901A3 (en) Systems and methods for delivery of a medical device
BR112012030017A2 (pt) cateter-balão revestido com um agente antirrestenótico e um dispersante molecular de promoção de transporte
PH12015500115B1 (en) Glucagon analogues
EP2921198A3 (en) Stability device for use with percutaneous delivery systems
WO2011121453A3 (en) Methods and compositions for treating or ameliorating cancer using gemcitabine-5'-elaidate
GT201400161A (es) Fenilimidazopirazoles sustituidos y su uso
MY169099A (en) Injectable formulation
UA118576C2 (uk) Фармацевтична композиція, яка містить бринзоламід
RU2017141536A (ru) Замещенные производные индол-5-ола и их терапевтические применения
MX337464B (es) Profarmacos lipofilicos labiles al acido de los agentes quimioterapeuticos contra el cancer.
BR112014009242A8 (pt) nanossuspensão farmacêutica
WO2015001163A3 (es) Nanopartículas lipídicas para la cicatrización de heridas
BR112014015578A8 (pt) composições farmacêuticas tópicas compreendendo bexaroteno e um corticosteróide
ZA201404068B (en) The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents
TR201911194T4 (tr) Solunabilir bir ilaç.
FR2994848B1 (fr) Traitement de l'arthrose par les hormones incretines ou leurs analogues
FR2976943B1 (fr) Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance
FR2976942B1 (fr) Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance
WO2013035053A3 (en) Novel conjugation-facilitated transport of drugs across blood brain barrier
RU2012123184A (ru) Способ управляемого снижения агрегационной активности тромбоцитов мексидолом в эксперименте
UA62795U (ru) Способ предупреждения развития катаракты у больных кератитом

Legal Events

Date Code Title Description
FG Grant or registration